| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/28/2010 | EP2210601A1 Anti-fatigue agent comprising amino acid composition |
| 07/28/2010 | EP2210600A1 Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine |
| 07/28/2010 | EP2209771A1 Cyclobutyl carboxylic acid derivatives |
| 07/28/2010 | EP2016080B1 Dihydropyrazolopyrimidinone derivatives |
| 07/28/2010 | EP1827406B1 Anti-radical agents |
| 07/28/2010 | EP1551844B1 Antitumoral analogs of lamellarins |
| 07/28/2010 | EP1487856B1 Human antibodies specific to kdr and uses thereof |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | EP1432403B1 Liposome loading with metal ions |
| 07/28/2010 | EP1369418B1 Quinazoline derivatives |
| 07/28/2010 | EP1315831B1 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN1895328B Use of persimmon-plant material in preparation of oxygen-tolerent and anti-fatigue composition |
| 07/28/2010 | CN101790377A Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
| 07/28/2010 | CN101787379A Preparation of microbial oil containing polyunsaturated fatty acids |
| 07/28/2010 | CN101787078A Collagen polypeptide, preparation method and application thereof |
| 07/28/2010 | CN101787017A Optical pure quinazoline compound |
| 07/28/2010 | CN101787008A N-acetyl neuraminic acid compounds, medicine compositions thereof and preparation methods and purposes thereof |
| 07/28/2010 | CN101785848A Traditional Chinese medicine combination and preparation method thereof for hypochondriac pain treatment |
| 07/28/2010 | CN101785830A Antibacterial agent and antibacterial composition |
| 07/28/2010 | CN101785828A Method for producing health care black bone chicken egg and employed pharmaceutical composition |
| 07/28/2010 | CN101785819A Traditional Chinese medicine combination and preparation method thereof for hydrothorax treatment |
| 07/28/2010 | CN101785772A Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
| 07/28/2010 | CN101292976B Medicament combination containing 1,8-eudesmin and flavanones, and uses thereof |
| 07/28/2010 | CN101147581B White Chinese sorghum nutritive powder and preparation method thereof |
| 07/27/2010 | US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis |
| 07/27/2010 | US7763738 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 07/27/2010 | US7763729 Bicyclic heteroaromatic derivatives |
| 07/27/2010 | US7763662 reducing weight in mammals; Substituted with a thio, sulfoxy or sulfonyl group eg 5-Chloro-2-methylsulfonylindan-1-ol, 5-Chloro-2-(propane-2-sulfonyl)indan-1-ol, 5-Chloro-2-ethanesulfonylindan-1-ol |
| 07/27/2010 | US7763641 such as [(1S,2R)-2-hydroxy-3-[N-[4-(2-methylaminothiazol-4-yl)phenylsulfonyl]-N-(2-methylpropyl)amino]-1-(phenylmethyl)propyl]carbamic acid, [(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]ester, used for treating human immunodeficiency virus infections |
| 07/27/2010 | US7763631 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 07/27/2010 | US7763610 cysteinyl leukotriene antagonists such as 4-(3-carboxypropyl)-8-((4-(4-phenylbutoxy)benzoyl)amino)-3,4-dihydro-2H-1,4-benzoxazine-2-carboxylic acid, used for treating asthma, chronic obstructive pulmonary disease, pneumonia, rhinitis and as expectorants or antitussives |
| 07/27/2010 | US7763597 Salts |
| 07/27/2010 | US7763591 Hepatocyte growth factor gene as an active therapeutic agent; biodrugs; Parkinson's disease, Alzheimer's disease, spinal cord injury, diabetic peripheral neuritis, and ischemic cerebrovascular disorders (cerebral infarction, cerebral haemorrhage) |
| 07/27/2010 | US7763422 evaluating the amount of cancer cells existing in pancreatic cells or tissues, by measuring the methylation frequency of Fibrillin2 gene or an index value having the correlation therewith, and comparing with a control; medical diagnosis |
| 07/27/2010 | US7763290 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 07/27/2010 | US7763284 Method for treating or preventing symptoms associated with menopause |
| 07/27/2010 | US7763255 Therapeutic uses of Dunaliella powder |
| 07/27/2010 | US7763252 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |
| 07/27/2010 | US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient. |
| 07/27/2010 | CA2629339C Pyrazolo[4,3-d]pyrimidin-5-yl) derivative used as pde5 inhibitors |
| 07/27/2010 | CA2610166C Benzoquinolinesulfonamide derivatives useful as rho-kinase inhibitors |
| 07/27/2010 | CA2481241C Fused quinoxaline derivatives as inhibitors of akt activity |
| 07/27/2010 | CA2466560C Acetylene derivatives having mglur5 antagonistic activity |
| 07/27/2010 | CA2463084C Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| 07/27/2010 | CA2461060C Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 07/27/2010 | CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/27/2010 | CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives |
| 07/27/2010 | CA2444266C Use of bile acid or bile salt fatty acid conjugates |
| 07/27/2010 | CA2375820C The myostatin gene promoter and inhibition of activation thereof |
| 07/27/2010 | CA2373559C Serotonin transport inhibitors |
| 07/27/2010 | CA2287872C Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/27/2010 | CA2224080C Relaxin-like factor and methods and uses thereof |
| 07/22/2010 | WO2010083439A2 Recombinant human albumin-human granulocyte colony stimulating factor for the prevention of neutropenia |
| 07/22/2010 | WO2010083328A2 Methods for screening and compounds that protect against amyloid diseases |
| 07/22/2010 | WO2010083107A1 Biocompatible microbubbles to deliver radioactive compounds to tumors, atherosclerotic plaques, joints and other targeted sites |
| 07/22/2010 | WO2010082661A1 1,5-ag-containing composition |
| 07/22/2010 | WO2010082612A1 Imidazothiazole derivative having proline ring structure |
| 07/22/2010 | WO2010082601A1 Novel 2,5-disubstituted pyrrole derivative |
| 07/22/2010 | WO2010082531A1 Active blood coagulation factor inhibitor |
| 07/22/2010 | WO2010081862A2 Methods and preparations for protecting critically ill patients |
| 07/22/2010 | WO2010053606A3 Small-molecule inhibitors of protein synthesis inactivating toxins |
| 07/22/2010 | WO2010034015A3 Modulating the alternative complement pathway |
| 07/22/2010 | US20100186097 Cell-based rna interference and related methods and compositions |
| 07/22/2010 | US20100185156 Methods and Devices for Minimally-Invasive Delivery of Cell-Containing Flowable Compositions |
| 07/22/2010 | US20100184863 Synthetic spilanthol and use thereof |
| 07/22/2010 | US20100184841 Extended dicer substrate agents and methods for the specific inhibition of gene expression |
| 07/22/2010 | US20100184833 Methods and means for treating dna repeat instability associated genetic disorders |
| 07/22/2010 | US20100184827 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184805 Renin inhibitors |
| 07/22/2010 | US20100184803 Treatment of Lysosomal Storage Diseases |
| 07/22/2010 | US20100184796 Agonists of bitter taste receptors and uses thereof |
| 07/22/2010 | US20100184793 Compositions incorporating sesamin-class compounds and vitamin b1 class compounds |
| 07/22/2010 | US20100184784 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 07/22/2010 | US20100184754 Quinolinone derivatives |
| 07/22/2010 | US20100184718 Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells |
| 07/22/2010 | US20100184717 Treatment of Statin Side Effects Using Uridine Derivatives |
| 07/22/2010 | US20100184690 Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications |
| 07/22/2010 | US20100184686 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer |
| 07/22/2010 | US20100184091 Method for determining MIF content |
| 07/22/2010 | US20100183748 Methods for Treating or Preventing Radiocontrast Agent Induced Kidney Injury |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183698 Methods for producing biomaterials with variable stiffness |
| 07/22/2010 | US20100183697 Tissue-separating fatty acid adhesion barrier |
| 07/22/2010 | US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport |
| 07/22/2010 | US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof |
| 07/22/2010 | US20100183558 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules |
| 07/22/2010 | DE202009002804U1 Zusammensetzung zur Pufferung unphysiologisch niedriger pH-Werte im Pansen Composition for buffering unphysiologically lower pH values in the rumen |
| 07/22/2010 | CA2750009A1 Imidazothiazole derivatives having proline ring structure |
| 07/22/2010 | CA2749802A1 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein |
| 07/22/2010 | CA2749163A1 Methods for screening and compounds that protect against amyloid diseases |
| 07/21/2010 | EP2208782A2 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 07/21/2010 | EP2208728A1 Heterocyclic derivative having inhibitory activity on type-i 11 -hydroxysteroid dehydrogenase |
| 07/21/2010 | EP2208499A1 Nucleic acid capable of regulating the proliferation of cell |
| 07/21/2010 | EP2208497A1 Use of Ursodeoxycholic acid (UDCA) for enhancing the general health condition of a tumor patient |
| 07/21/2010 | EP2207550A2 Tetrahydroquinoline derivatives for treating post-traumatic stress disorders |
| 07/21/2010 | EP1487444B9 Use of pyridyl amides as inhibitors of angiogenesis |
| 07/21/2010 | EP1474121B1 Synergistic association of (-)- gossypol with docetaxel or paclitaxel for cancer treatment |
| 07/21/2010 | EP1444516B1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |